Plunkett Research Online: Kintara Therapeutics Inc

KINTARA THERAPEUTICS INC (KTRA) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Kintara Therapeutics Inc is engaged in the development of novel cancer therapies for patients with unmet medical needs. The company is developing two late-stage, Phase 3-ready therapeutics for clear unmet medical needs with reduced risk development programs. The two programs are VAL-083 for GBM and .....


KINTARA THERAPEUTICS INC

Ticker: KTRA
Exchange: NAS
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 858 350-4364
Fax:
Address: 12707 High Bluff Drive
San Diego, CA 92130 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Contacts Description

Robert HoffmanCEO/CFO/Chairman of the Board/Director/President
Robert TothDirector
See More
Kintara Therapeutics Inc is engaged in the development of novel cancer therapies for patients with unmet medical needs. The company is developing two late-stage, Phase 3-ready therapeutics for clear unmet medical needs with reduced risk development programs. The two programs are VAL-083 for GBM and .....See More See More

$USD, In whole numbers2023202220212020201920182017
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture